المصدر: An Open-label, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06431776Test

المصدر: A Randomized, Double-blind, Placebo-controlled Clinical Trial of Once-daily Inhaled Molgramostim Nebulizer Solution in Adult Subjects With Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04544293Test

المصدر: An Open-label, Non-controlled, Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03482752Test

المؤلفون: Rare Diseases Clinical Research Network, National Center for Advancing Translational Sciences (NCATS)

المصدر: Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03006146Test

المصدر: Trapnell BC, oue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, Campo Pap SA, YamaguchE, Cetkaya E, kovh MM, Kramer MR, Veltkamp M, Kreuter M, Baba T, Ganslandt C, Tarnow Waterer G, Jouhaen T; PALA Trl vestators. haled Molgramost Therapy Automune Pulmonary Alveolar Proteos. N Engl J Med. 2020 Oct 22;383(17):1635-1644. do 10.1056/NEJMoa1913590. Epub 2020 Sep 7.
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02702180Test